Form 4: CONMED Corp CEO Curt Hartman Granted Stock Options

CONMED Corp's CEO, Curt Hartman, was granted 79,154 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.

Summary

• Curt R. Hartman, the President, CEO, and Chair of CONMED Corp, was granted 79,154 stock options on March 1, 2024.
• The options were granted under the company's 2018 Long-Term Incentive Plan.
• The exercise price of the options is $79.95.
• The options vest in equal amounts over a five-year period.
• Hartman also has a Power of Attorney agreement in place, allowing designated individuals to execute securities filings on his behalf.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests. The sentiment is moderately positive due to the incentive structure.

Positives

• The granting of stock options aligns the CEO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CEO.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in publicly traded companies, particularly in the healthcare and medical device sectors.
• Companies like Medtronic, Stryker, and Johnson & Johnson also utilize stock options as part of their executive compensation plans.
• The vesting schedule of five years is fairly standard, encouraging long-term commitment from the executive.
• The specific number of options granted and the exercise price would need to be compared against industry benchmarks and CONMED's historical practices to determine if they are in line with expectations.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the CEO to drive long-term value.
• Employees may see the grant as a sign of confidence in the company's future.

Key Dates